- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Prenetics Global Ltd (PRE)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/12/2025: PRE (2-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $31
1 Year Target Price $31
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 44.81% | Avg. Invested days 25 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 249.99M USD | Price to earnings Ratio - | 1Y Target Price 31 |
Price to earnings Ratio - | 1Y Target Price 31 | ||
Volume (30-day avg) 1 | Beta 0.34 | 52 Weeks Range 3.09 - 17.99 | Updated Date 12/13/2025 |
52 Weeks Range 3.09 - 17.99 | Updated Date 12/13/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.59 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -60.39% | Operating Margin (TTM) -26.17% |
Management Effectiveness
Return on Assets (TTM) -14.78% | Return on Equity (TTM) -30.08% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 228365431 | Price to Sales(TTM) 3.24 |
Enterprise Value 228365431 | Price to Sales(TTM) 3.24 | ||
Enterprise Value to Revenue 3.1 | Enterprise Value to EBITDA 0.14 | Shares Outstanding 15247465 | Shares Floating 10710292 |
Shares Outstanding 15247465 | Shares Floating 10710292 | ||
Percent Insiders 18.18 | Percent Institutions 10.39 |
About Prenetics Global Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2022-05-18 | Co-Founder, Chairperson & CEO Mr. Sheng Wu Yeung | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 285 | Website https://www.prenetics.com |
Full time employees 285 | Website https://www.prenetics.com | ||
Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into health, wellness, and genetic predispositions. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

